HighMid-20s to 50s

Genomics Revolution Portfolio

Investing in biotech innovation including CRISPR, gene therapy, and precision medicine

Expected Return

11-16% annually

Expected Dividend

0.5% annually

Rebalancing

Monthly

Asset Allocation

ARKG (30%)

GNOM (25%)

IDNA (20%)

IBB (15%)

XBI (10%)

ARKG

ARK Genomic Revolution ETF

30%

GNOM

Genomics and biotech

25%

IDNA

Genomics index

20%

IBB

Biotech

15%

XBI

Biotech SPDR

10%

Advantages

✓Medical revolution
✓Personalized treatments
✓Vast addressable market

Risks

!Clinical trial failures
!Regulatory delays
!Ethical controversies

Allocation by Investment Amount

If investing $1,000

ARKG$300

GNOM$250

IDNA$200

IBB$150

XBI$100

If investing $5,000

ARKG$1500

GNOM$1250

IDNA$1000

IBB$750

XBI$500

If investing $10,000

ARKG$3000

GNOM$2500

IDNA$2000

IBB$1500

XBI$1000